Development and clinical validation of a molecular diagnostic assay to detect CTX-M-type β-lactamases in Enterobacteriaceae

Clinical Microbiology and Infection

Volumn 13, Issue 3, 2007, Pages 291-297

  Pitout, Johann D D ^a,b   Hamilton, N ^a   Church, D L ^a,b,c   Nordmann, P ^d   Poirel, L ^d  

^a CALGARY LABORATORY SERVICES   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

^c UNIVERSITY OF CALGARY   (Canada)

^d BICÊTRE HOSPITAL   (France)

Author keywords

CTX Menzymes; Detection; Enterobacteriaceae; PCR; Surveillance; Lactamase

Indexed keywords

BETA LACTAMASE; BETA LACTAMASE AMPC; BETA LACTAMASE CTX M; BETA LACTAMASE INHIBITOR; CEFOTAXIME; CEFOXITIN; CEFTAZIDIME; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; COTRIMOXAZOLE; GENTAMICIN; IMIPENEM; PIPERACILLIN PLUS TAZOBACTAM; TOBRAMYCIN; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; COMMUNITY; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; ENTEROBACTERIACEAE; HOSPITAL; LABORATORY TEST; NONHUMAN; PLASMID; POLYMERASE CHAIN REACTION; PREDICTION; PRIORITY JOURNAL; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; VALIDATION PROCESS;

ENTEROBACTERIACEAE;

EID: 34247161040     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2006.01645.x     Document Type: Article

References (48)

1. Bradford PA. Extended-spectrum β-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin Microbiol Rev 2001; 14: 933-951.
2. Paterson DL, Bonomo RA. Extended-spectrum β-lactamases: A clinical update. Clin Microbiol Rev 2005; 18: 657-686.
3. Pitout JD, Nordmann P, Laupland KB, Poirel L. Emergence of Enterobacteriaceae producing extended-spectrum β-lactamases (ESBLs) in the community. J Antimicrob Chemother 2005; 56: 52-59.
4. Bonnet R. Growing group of extended-spectrum β-Lactamases: The CTX-M enzymes. Antimicrob Agents Chemother 2004; 48: 1-14.
5. Mulvey MR, Bryce E, Boyd D et al. Ambler class A extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella spp. in Canadian hospitals. Antimicrob Agents Chemother 2004; 48: 1204-1214.
6. Pitout JD, Hanson ND, Church DL, Laupland KB. Population-based laboratory surveillance for Escherichia coli producing extended-spectrum β-lactamases: Importance of community isolates with bla CTX-M genes. Clin Infect Dis 2004; 38: 1736-1741.
7. Rodriguez-Bano J, Navarro MD, Romero L et al. Epidemiology and clinical features of infections caused by extended-spectrum β-lactamase-producing Escherichia coli in nonhospitalized patients. J Clin Microbiol 2004; 42: 1089-1094.
8. Rodriguez-Bano J, Navarro MD, Romero L et al. Clinical and molecular epidemiology of extended-spectrum β-lactamase-producing Escherichia coli as a cause of nosocomial infection or colonization: Implications for control. Clin Infect Dis 2006; 42: 37-45.
9. Valverde A, Coque TM, Sanchez-Moreno MP et al. Dramatic increase in prevalence of fecal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae during nonoutbreak situations in Spain. J Clin Microbiol 2004; 42: 4769-4775.
10. Lartigue MF, Fortineau N, Nordmann P. Spread of novel expanded-spectrum β-lactamases in Enterobacteriaceae in a university hospital in the Paris area, France. Clin Microbiol Infect 2005; 11: 588-591.
11. Kim J, Lim YM, Jeong YS, Seol SY. Occurrence of CTX-M-3, CTX-M-15, CTX-M-14, and CTX-M-9 extended-spectrum β-lactamases in Enterobacteriaceae clinical isolates in Korea. Antimicrob Agents Chemother 2005; 49: 1572-1575.
12. Woodford N, Ward ME, Kaufmann ME et al. Community and hospital spread of Escherichia coli producing CTX-M extended-spectrum β-lactamases in the UK. J Antimicrob Chemother 2004; 54: 735-743.
13. Pitout JD, Gregson DB, Church DL, Elsayed S, Laupland KB. Community-wide outbreaks of clonally related CTX-M-14 β-lactamase-producing Escherichia coli strains in the Calgary Health Region. J Clin Microbiol 2005; 43: 2844-2849.
14. Bou G, Cartelle M, Tomas M et al. Identification and broad dissemination of the CTX-M-14 β-lactamase in different Escherichia coli strains in the northwest area of Spain. J Clin Microbiol 2002; 40: 4030-4036.
15. Garcia A, Navarro F, Miro E et al. Characterization of the highly variable region surrounding the bla (CTX-M-9) gene in non-related Escherichia coli from Barcelona. J Antimicrob Chemother 2005; 56: 819-826.
16. Canton R, Oliver A, Coque TM et al. Epidemiology of extended-spectrum β-lactamase-producing Enterobacter isolates in a Spanish hospital during a 12-year period. J Clin Microbiol 2002; 40: 1237-1243.
17. Chanawong A, M'Zali FH, Heritage J, Xiong JH, Hawkey PM. Three cefotaximases, CTX-M-9, CTX-M-13, and CTX-M-14, among Enterobacteriaceae in the People's Republic of China. Antimicrob Agents Chemother 2002; 46: 630-637.
18. Batchelor M, Hopkins K, Threlfall EJ et al. bla (CTX-M) genes in clinical Salmonella isolates recovered from humans in England and Wales from 1992 to 2003. Antimicrob Agents Chemother 1992; 49: 1319-1322.
19. Saladin M, Cao VT, Lambert T et al. Diversity of CTX-M β-lactamases and their promoter regions from Enterobacteriaceae isolated in three Parisian hospitals. FEMS Microbiol Lett 2002; 209: 161-168.
20. Woodford N, Fagan EJ, Ellington MJ. Multiplex PCR for rapid detection of genes encoding CTX-M extended-spectrum β-lactamases. J Antimicrob Chemother 2006; 57: 154-155.
21. Black JA, Thomson KS, Buynak JD, Pitout JD. Evaluation of β-lactamase inhibitors in disk tests for detection of plasmid-mediated AmpC β-lactamases in well-characterized clinical strains of Klebsiella spp. J Clin Microbiol 2005; 43: 4168-4171.
22. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing, 14th informational supplement. M100-S14. Wayne, PA: National Committee for Clinical Laboratory Standards, 2004.
23. Pitout J.D. Reisbig M.D. Venter E.C. Church D.L. Hanson N.D. Modification of the double-disk test for detection of enterobacteriaceae producing extended-spectrum and AmpC β-lactamases. J Clin Microbiol 2003; 41: 3933-3935.
24. Kariyama R, Mitsuhata R, Chow JW, Clewell DB, Kumon H. Simple and reliable multiplex PCR assay for surveillance isolates of vancomycin-resistant enterococci. J Clin Microbiol 2000; 38: 3092-3095.
25. Lartigue MF, Poirel L, Nordmann P. Diversity of genetic environment of bla (CTX-M) genes. FEMS Microbiol Lett 2004; 234: 201-207.
26. Pitout JD, Hossain A, Hanson ND. Phenotypic and molecular detection of CTX-M-β-lactamases produced by Escherichia coli and Klebsiella spp. J Clin Microbiol 2004; 42: 5715-5721.
27. Forbes BA. Introducing a molecular test into the clinical microbiology laboratory: Development, evaluation, and validation Arch Pathol Lab Med 2003; 127: 1106-1111.
28. Pitout JD, Thomson KS, Hanson ND et al. β-Lactamases responsible for resistance to expanded-spectrum cephalosporins in Klebsiella pneumoniae, Escherichia coli, and Proteus mirabilis isolates recovered in South Africa. Antimicrob Agents Chemother 1998; 42: 1350-1354.
29. Woodford N, Sundsfjord A. Molecular detection of antibiotic resistance: when and where? J Antimicrob Chemother 2005; 56: 259-261.
30. Sundsfjord A, Simonsen GS, Haldorsen BC et al. Genetic methods for detection of antimicrobial resistance. APMIS 2004; 112: 815-837.
31. Dutour C, Bonnet R, Marchandin H et al. CTX-M-1, CTX-M-3, and CTX-M-14 β-lactamases from Enterobacteriaceae isolated in France. Antimicrob Agents Chemother 2002; 46: 534-537.
32. Bonnet R, Sampaio JL, Labia R et al. A novel CTX-M β-lactamase (CTX-M-8) in cefotaxime-resistant Enterobacteriaceae isolated in Brazil. Antimicrob Agents Chemother 2000; 44: 1936-1942.
33. Gniadkowski M, Schneider I, Palucha A et al. Cefotaxime-resistant Enterobacteriaceae isolates from a hospital in Warsaw, Poland: identification of a new CTX-M-3 cefotaxime-hydrolyzing β-lactamase that is closely related to the CTX-M-1/MEN-1 enzyme. Antimicrob Agents Chemother 1998; 42: 827-832.
34. Bradford PA, Yang Y, Sahm D et al. CTX-M-5, a novel cefotaxime-hydrolyzing β-lactamase from an outbreak of Salmonella typhimurium in Latvia. Antimicrob Agents Chemother 1998; 42: 1980-1984.
35. Sabate M, Tarrago R, Navarro F et al. Cloning and sequence of the gene encoding a novel cefotaxime-hydrolyzing β-lactamase (CTX-M-9) from Escherichia coli in Spain. Antimicrob Agents Chemother 2000; 44: 1970-1973.
36. Oliver A, Perez-Diaz JC, Coque TM, Baquero F, Canton R. Nucleotide sequence and characterization of a novel cefotaxime-hydrolyzing β-lactamase (CTX-M-10) isolated in Spain. Antimicrob Agents Chemother 2001; 45: 616-620.
37. Ma L, Ishii Y, Chang FY et al. CTX-M-14, a plasmid-mediated CTX-M type extended-spectrum β-lactamase isolated from Escherichia coli. Antimicrob Agents Chemother 2002; 46: 1985-1988.
38. Baraniak A, Fiett J, Hryniewicz W, Nordmann P, Gniadkowski M. Ceftazidime-hydrolysing CTX-M-15 extended-spectrum β-lactamase (ESBL) in Poland. J Antimicrob Chemother 2002; 50: 393-396.
39. Boyd DA, Tyler S, Christianson S et al. Complete nucleotide sequence of a 92-kilobase plasmid harboring the CTX-M-15 extended-spectrum β-lactamase involved in an outbreak in long-term-care facilities in Toronto, Canada. Antimicrob Agents Chemother 2004; 48: 3758-3764.
40. Bonnet R, Dutour C, Sampaio JL et al. Novel cefotaximase (CTX-M-16) with increased catalytic efficiency due to substitution Asp-240→Gly. Antimicrob Agents Chemother 2001; 45: 2269-2275.
41. Cao V, Lambert T, Courvalin P. ColE1-like plasmid pIP843 of Klebsiella pneumoniae encoding extended-spectrum β-lactamase CTX-M-17. Antimicrob Agents Chemother 2002; 46: 1212-1217.
42. Poirel L, Naas T, Le T et al. CTX-M-type extended-spectrum β-lactamase that hydrolyzes ceftazidime through a single amino acid substitution in the omega loop. Antimicrob Agents Chemother 2001; 45: 3355-3361.
43. Munday CJ, Boyd DA, Brenwald N et al. Molecular and kinetic comparison of the novel extended-spectrum β-lactamases CTX-M-25 and CTX-M-26. Antimicrob Agents Chemother 2004; 48: 4829-4834.
44. Abdalhamid B, Pitout JD, Moland ES, Hanson ND. Community-onset disease caused by Citrobacter freundii producing a novel CTX-M β-lactamase, CTX-M-30, in Canada. Antimicrob Agents Chemother 2004; 48: 4435-4437.
45. Ishii Y, Ohno A, Taguchi H et al. Cloning and sequence of the gene encoding a cefotaxime-hydrolyzing class A β-lactamase isolated from Escherichia coli. Antimicrob Agents Chemother 1995; 39: 2269-2275.
46. Poirel L, Pitout JD, Calvo L et al. In vivo selection of fluoroquinolone-resistant Escherichia coli isolates expressing plasmid-mediated quinolone resistance and expanded-spectrum β-lactamase. Antimicrob Agents Chemother 2006; 50: 1525-1527.
47. Ehrhardt AF, Sanders CC, Moland ES. Use of an isogenic Escherichia coli panel to design tests for discrimination of β-lactamase functional groups of Enterobacteriaceae. Antimicrob Agents Chemother 1999; 43: 630-633.
48. Pitout JD, Reisbig MD, Mulvey M et al. Association between handling of pet treats and infection with Salmonella enterica serotype Newport expressing the AmpC β-lactamase, CMY-2. J Clin Microbiol 2003; 41: 4578-4582.